Rochester, Minn.-based Mayo Clinic is among the investors in a $7.3 million seed funding round for Olive Diagnostics, a company that makes an artificial intelligence-powered device that can be placed on toilets to analyze urine for conditions like kidney stones and heart failure, VentureBeat reported recently.
Read the full post on Becker's Hospital Review - Healthcare News
